Similar articles

• Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones.

  Walbrown MA, Aspinall SL, Bayliss NK, Stone RA, Cunningham F, Squier CL, Good CB. Walbrown MA, et al. J Manag Care Pharm. 2008 Jan-Feb;14(1):34-40. doi: 10.18553/jmcp.2008.14.1.34. J Manag Care Pharm. 2008. PMID: 18240880 Free PMC article.
• Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

  Gaynes R, Rimland D, Killum E, Lowery HK, Johnson TM 2nd, Killgore G, Tenover FC. Gaynes R, et al. Clin Infect Dis. 2004 Mar 1;38(5):640-5. doi: 10.1086/381551. Epub 2004 Feb 11. Clin Infect Dis. 2004. PMID: 14986246
• A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

  Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, Posey K, Roberts T, Croyle K, Krystofiak S, Patel-Brown S, Pasculle AW, Paterson DL, Saul M, Harrison LH. Muto CA, et al. Infect Control Hosp Epidemiol. 2005 Mar;26(3):273-80. doi: 10.1086/502539. Infect Control Hosp Epidemiol. 2005. PMID: 15796280
• Clostridium difficile-associated diarrhea: resurgence with a vengeance.

  Oldfield EC 3rd. Oldfield EC 3rd. Rev Gastroenterol Disord. 2006 Spring;6(2):79-96. Rev Gastroenterol Disord. 2006. PMID: 16699477 Review.
• Clostridium difficile in children: colonisation and disease.

  Enoch DA, Butler MJ, Pai S, Aliyu SH, Karas JA. Enoch DA, et al. J Infect. 2011 Aug;63(2):105-13. doi: 10.1016/j.jinf.2011.05.016. Epub 2011 Jun 12. J Infect. 2011. PMID: 21664931 Review.